Meridian Bioscience, Inc. (MB) is a local bioscience firm with a global reach.
On January 27 MB made known two new distribution deals that will increase sales in the far flung lands of Argentina and Australia.
MB has signed distribution agreements with Australian Immuno Pty, Ltd (IP) and Argentine Scott Pharma (SP). These deals come at a good time since MB has stated its commitment to expand its global market.
"Following a thorough evaluation of the Australian and Argentinean markets, it is clear that Immuno Pty and Scott Pharma business models align very well with ours," says Todd Motto, Vice President of Sales and Marketing at MB. "We're confident that this combination of market expertise and Meridian's superior quality products will be very successful."
With Sydney-based IP's 25 years of experience in the Australian diagnostic field, and SP's 61 years as a healthcare distributor, based in Buenos Aires, MB's new partners bring market expertise that is poised to ensure growth for MB.
MB sees research and innovation in the area of infectious disease as one of its greatest potential areas for global growth.
"The effective global distribution of our rapid tests for infectious disease is one of Meridian's key strategies," says John A. Kraeutler, MB's Chief Executive Officer. "By working closely with ideal partners, such as Immuno Pty and Scott Pharma, we can provide opportunities for long-term growth for Meridian and its distributors around the world."
MB's product used for discovering the nasty and often deadly E. coli virus shows great potential to save lives and promote company growth.
Concurring, Dr. Adrian Uccello, SP's Director, says, "We are particularly excited about the opportunities for E. coli detection with their innovative ImmunoCard STAT ® EHEC product."
Ultimately, all three companies share a passionate commitment to developing solutions to ensure continual innovation in lab research, and subsequently, improved health for all.
"Meridian's focus is the same as ours," says Martin Armstrong, IP's Chief Executive Officer. "Immuno is very excited to add Meridian Bioscience to our offerings and look forward to serving all of the needs in the microbiology and infectious disease testing area of the laboratory."
Writer: Jonathan DeHart
Source: Meridian Bioscience, Inc.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.